Griswold
SPONSORED
Main Street Nashville: Griswold Home Care Raises Awareness for World MS Day 5/30
The brand’s CEO Michael Slupecki and Nashville franchisee Beth Walrich discuss the signs of MS and progress made to treat the disease over the years.

Multiple sclerosis (MS) is a debilitating disease that attacks the central nervous system. World MS Day is recognized on May 30 each year to help raise awareness about the disease and fight for quality care for those suffering from it. This year, bringing awareness to the disease is even more important as MS patients are at a higher risk for COVID-19. Michael Slupecki, CEO of Griswold Home Care, and Beth Walrich, a Nashville franchisee for the brand, recently discussed symptoms of the disease and progress made to treat it in a Main Street Nashville article.
More than 1 million people in the U.S. over the age of 18 live with a diagnosis of MS. The disease is life-altering and causes fatigue, numbness, tingling, blurred vision, double vision, weakness, poor coordination, imbalance, pain, memory problems and even depression. The problem with these symptoms, both emotional and physical, is that they often go unseen by friends and family members, making those suffering feel even more alone. That’s why it’s important to keep an eye out for any of the above symptoms and provide those diagnosed with extra support throughout their struggles.
“Realize that you are dealing with someone who’s still very much alive and wants to be loved and surrounded by family and friends,” Walrich told Main Street Nashville.
The good news is that there has been a lot of scientific progress made to help treat the disease. Steroids, injections and IV treatments have proven to be solid methods to help those with the disease continue on with their lives.
“It’s great to know when you look at statistics how much progress has been made with the treatment of MS even over the last 25 years,” Slupecki told Main Street Nashville. “My goal in MS is to never have to care for anyone that has MS.”
To read the full article, click here.
Griswold
SPONSORED
The brand’s CEO Michael Slupecki and Nashville franchisee Beth Walrich discuss the signs of MS and progress made to treat the disease over the years.

Multiple sclerosis (MS) is a debilitating disease that attacks the central nervous system. World MS Day is recognized on May 30 each year to help raise awareness about the disease and fight for quality care for those suffering from it. This year, bringing awareness to the disease is even more important as MS patients are at a higher risk for COVID-19. Michael Slupecki, CEO of Griswold Home Care, and Beth Walrich, a Nashville franchisee for the brand, recently discussed symptoms of the disease and progress made to treat it in a Main Street Nashville article.
More than 1 million people in the U.S. over the age of 18 live with a diagnosis of MS. The disease is life-altering and causes fatigue, numbness, tingling, blurred vision, double vision, weakness, poor coordination, imbalance, pain, memory problems and even depression. The problem with these symptoms, both emotional and physical, is that they often go unseen by friends and family members, making those suffering feel even more alone. That’s why it’s important to keep an eye out for any of the above symptoms and provide those diagnosed with extra support throughout their struggles.
“Realize that you are dealing with someone who’s still very much alive and wants to be loved and surrounded by family and friends,” Walrich told Main Street Nashville.
The good news is that there has been a lot of scientific progress made to help treat the disease. Steroids, injections and IV treatments have proven to be solid methods to help those with the disease continue on with their lives.
“It’s great to know when you look at statistics how much progress has been made with the treatment of MS even over the last 25 years,” Slupecki told Main Street Nashville. “My goal in MS is to never have to care for anyone that has MS.”
To read the full article, click here.
Sign up for the 1851 Franchise newsletter to get our biggest stories before everyone else
By signing up, you agree to our user agreement (including class action waiver and arbitration provisions), and acknowledge our privacy policy.

No related articles found